A newly developed antibody-based treatment and protein-based vaccine reduced Alzheimer’s symptoms in mouse models, researchers report.
A promising new approach to potentially treat Alzheimer’s disease—and also vaccinate against it—has been developed by a team of UK and German scientists.
Both the antibody-based treatment and the protein-based vaccine developed by the team reduced Alzheimer’s symptoms in mouse models of the disease.
@disk4mat if this works out, it's fantastic news. it's still early days though.